US-based MedTech Innovator, the world’s largest accelerator of medical technology companies, in partnership with Singapore-based Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, have announced that Medipixel is the winner of the 2023 Asia Pacific (APAC) Accelerator programme.

The winning company was determined by a live audience vote during the MedTech Innovator Asia Pacific 2023 Grand Finals hosted by MedTech Innovator in partnership with APACMed at the APACMed MedTech Forum, last week in Singapore.

Medipixel is a South Korea-based company that has developed MPXA, empowering physicians to better diagnose and treat Cardiovascular Disease, the leading cause of death in the world. Leveraging artificial intelligence (AI), Medipixel provides rapid and real-time analysis solutions that can support physician decision-making during interventional procedures. The transformative healthtech AI company was awarded prestigious $175,000 Grand Prize.

The other finalists, Healium Medical (Israel), Module Innovations (India) and Vivo Surgical (Singapore) each received $10,000. Additionally, Neurowyzr was announced the winner of Enterprise Singapore’s (EnterpriseSG) Startup SG award, comprising an SGD$ 30,000 grant prize and access to extensive resources and networks within Singapore’s startup ecosystem.

Vesica AI was named the inaugural Olympus Asia Pacific Innovation Program winner and will receive grant funding of $75,000 as well as an exclusive mentorship program with key thought leaders from Olympus